Genta Incorporated
Two New Studies Show Gallium-Containing Compounds Significantly Increase Bone Strength in Standard Models of Osteoporosis
Published in Clinical Trials Week, January 25th, 2010
Genta Incorporated (OTCBB: GETA) announced publication of two scientific studies that test the active ingredient in Genta's program to develop orally available gallium-containing compounds and the Company's marketed product, Ganite® (gallium nitrate for injection). In these studies, a compound containing the active ingredient was tested in a widely accepted animal model of established osteoporosis. The new data show that extended treatment with the active ingredient significantly increased bone volume and calcium content in animals with induced osteoporosis. In addition, the increase in new bone formation was associated with a significant restoration of bone strength back to normal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2010-01-25)
More Articles from Clinical Trials Week
- American Association for Cancer Research
Gene testing identifies lung cancer patients who benefit from ALK-inhibitor drug - Absorption Systems
Study Shows the Unique Power of Absorption Systems' CellPort Technologies(TM) - Medifocus, Inc.
Medifocus, Inc. Announces Positive Clinical Results of Its Breast Cancer Treatment Studies Published in Annals of Surgical Oncology: Planning to Begin Phase III In Early 2010 - NewsRx
NewsRx Publishes Encyclopedia of Breast Cancer, 2009: an encyK Resource for Patients & Professionals - Onset Medical Corporation
Onset Medical Announces New Website www.onsetmedical.com - RegeneRx Biopharmaceuticals, Inc.
NIH Awards Over $5,000,000 for Tb4 Research in 2009/2010 - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
